Table 2 Individual data on the eight patients included in the study
From: The incretin effect in critically ill patients: a case–control study
Patient | Reason for admission to the ICU | Sex | APACHE II | Data from IVGI | OGTT on day after admission | Discharge destination | Days in ICU | Ventilator OGTT/IVGI | Mean/median (interquartile range) blood glucose 36 h before OGTT (mmol/L) | Total dose of insulin 36 h before OGTT (IU) | Total dose of steroida in ICU before OGTT (mg) | Dose of steroida OGTT/IVGI (mg/day) | Dose of NE OGTT/IVGI (mg/kg/day) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Sepsis (pneumonia) | Male | 27 | No | 2 | Ward | 2.8 | Yes | 8.2/7.7(6.4–8.7) | None | 18.7 | 3.7 | None/ |
2 | Sepsis (pneumonia) | Female | 34 | Yes | 2 | Deceased | 4.4 | Yes/Yes | 9.0/7.7(6.4–10.3) | 2 | None | None/11.2 | 0.53/1.15 |
3 | Sepsis (diverticulitis) | Male | 23 | No | 2 | Ward | 9.0 | No | 10.4/9.7(9.1–11.3) | None | None | None/ | None/ |
4 | Cardiogenic shock | Female | 25 | Yes | 2 | ICU at another hospital | 2.0 | No/No | 11.9/11.3(10.1–12.1) | None | 5.6 | 5.6/None | None/None |
5 | Hypothermia after cardiac arrest | Male | 41 | Yes | 4 | Deceased | 5.2 | Yes/Yes | 8.1/8.4(7.9–9.4) | 63 | None | None/None | None/None |
6 | Sepsis (pneumonia) | Female | 45 | Yes | 3 | Deceased | 4.1 | Yes/Yes | 8.2/7.4(6.6–8.5) | None | 18.8 | None/None | 0.04b/0.59 |
7 | Sepsis (pneumonia) | Male | 31 | Yes | 2 | Ward | 12.7 | No/Yes | 7.2/7.6(7.1–8.7) | None | None | None/None | None/None |
8 | Sepsis (pneumonia) | Female | 24 | Yes | 3 | Ward | 14.4 | Yes/Yes | 9.5/9.4 (7.9–10.9) | 48 | 11.2 | 5.6/5.6 | 0.04/0.20 |
Mean/median (interquartile range) | 31/28 (24–38) | 6.8/4.8 (3.5–10.8) | 9.1/8.6 (8.1–9.9) | 14.1/0.0 (0.0–25.0) | 6.8/2.8 (0.0–15.0) | 1.8/0.0 (0.0–4.7)/2.8/0.0 (0.0–5.6) | 0.08/0.00 (0.00–0.04)/0.32/0.10 (0.0–0.59) |